DiaMedica Therapeutics (DMA) News Today → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free DMA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDiaMedica Therapeutics Inc DMACmorningstar.com - February 16 at 7:01 PMDiaMedica Therapeutics Inc. (DMAC) Q4 2022 Earnings Call Transcriptseekingalpha.com - March 31 at 6:00 AMCerevel Therapeutics Holdings (CERE) Shares Cross Below 200 DMAnasdaq.com - February 24 at 6:45 PMDiaMedica stock slides 17% after hours as FDA maintains clinical hold on DM199 trialseekingalpha.com - October 26 at 7:49 PMMEXC Activated the "Investor Protection Fund" in Response to the Dragoma (DMA) Incident, and Launched the "Potion" Airdrop Compensation Benefitsfinance.yahoo.com - August 12 at 4:44 PMDiaMedica Therapeutics Announces Clinical Hold of DM199 Trial, Shares Fall 31%marketwatch.com - July 8 at 8:32 PMDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 7 at 12:16 AM Get DiaMedica Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DMA and its competitors with MarketBeat's FREE daily newsletter. Email Address One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. DMA Media Mentions By Week DMA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DMA News Sentiment▼0.000.44▲Average Medical News Sentiment DMA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DMA Articles This Week▼00▲DMA Articles Average Week Get DiaMedica Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IBEX Technologies News Aptose Biosciences News Covalon Technologies News Microbix Biosystems News Small Pharma News ProMIS Neurosciences News Ceapro News Reunion Neuroscience News Sirona Biochem News Kane Biotech News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:DMA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold GroupExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
